Inventor · disambiguated record
Xingchun Han
Also filed as: HAN XINGCHUN
23 granted patents·10 pending applications·134 citations·filing 2008–2024
94Inventor score
Top patents by PatentIndex Score
33 records- 0194US9458153B2Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Oct 4, 2016·23 cites·20 claims
- 0293US8076482B23,3′-spiroindolinone derivativesCHEN LI·Filed 2010·Granted Dec 13, 2011·28 cites·4 claims
- 0391US10093671B22-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2017·Granted Oct 9, 2018·14 cites·17 claims
- 0491US9845322B2Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Dec 19, 2017·7 cites·46 claims
- 0591US7776875B2Spiroindolinone derivativesHOFFMANN LA ROCHE·Filed 2008·Granted Aug 17, 2010·20 cites·12 claims
- 0689US7928233B2Spiroindolinone pyridine derivativesHOFFMANN LA ROCHE·Filed 2010·Granted Apr 19, 2011·7 cites·4 claims
- 0788US9637485B26,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted May 2, 2017·9 cites·25 claims
- 0887US11191775B2PAPD5 and PAPD7 inhibitors for treating a hepatitis B infectionHOFFMANN LA ROCHE·Filed 2017·Granted Dec 7, 2021·2 cites·8 claims
- 0985US10053461B2Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Aug 21, 2018·3 cites·21 claims
- 1083US9949966B2Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Apr 24, 2018·4 cites·21 claims
- 1183US9890167B2Pyrazine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2016·Granted Feb 13, 2018·4 cites·50 claims
- 1282US9920049B2Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Mar 20, 2018·5 cites·16 claims
- 1381US11104674B2Tetrahydropyridopyrimidines for the treatment of HBV infectionHOFFMANN LA ROCHE·Filed 2018·Granted Aug 31, 2021·2 cites·33 claims
- 1480US10336751B2Tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Jul 2, 2019·3 cites·12 claims
- 1580US10150740B26,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Dec 11, 2018·3 cites·15 claims
- 1673US2022096527A1Papd5 and papd7 inhibitors for treating a hepatitis b infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1772US12421211B2Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2023·Granted Sep 23, 2025·0 cites·15 claims
- 1865US11858912B2Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2022·Granted Jan 2, 2024·0 cites·16 claims
- 1965US2024140933A1Oxoindoline compound for the treatment of inflammatory diseases or cancerHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2065US2024376073A1Quaternary ammonium cation substituted compounds for the treatment of bacterial infectionsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2160US2023141403A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2258US2022396565A1Novel heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2354US2023012368A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2453US11225482B2Dihydropyrrolopyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Jan 18, 2022·0 cites·17 claims
- 2552US10683299B2Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2019·Granted Jun 16, 2020·0 cites·12 claims
- 2651US2022396567A1Substituted pyrimidine for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2750US11168086B2Methods of synthesizing pyrazine compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Nov 9, 2021·0 cites·20 claims
- 2847US10968218B2Tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2017·Granted Apr 6, 2021·0 cites·14 claims
- 2946US11447489B2Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Sep 20, 2022·0 cites·16 claims
- 3046US10781206B2Tetrahydropyrazolopyridine compounds for the treatment of infectious diseasesHOFFMANN LA ROCHE·Filed 2019·Granted Sep 22, 2020·0 cites·17 claims
- 3142US2023248723A1Pyrrolo[2,3-b]pyrazine compounds as cccdna inhibitors for the treatment of hepatitis b virus (hbv) infectionHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 3237US2010190814A1Spiroindolinone derivative prodrugsCHEN LI·Filed 2010·Application pending·0 cites
- 3334US2015266878A1Novel bi-ring phenyl-pyridines/pyrazines for the treatment of cancerHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xingchun Han files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →